Single trans-septal access technique for left atrial intracardiac echocardiography to guide left atrial appendage closure
Author
dc.contributor.author
Aguirre, Daniel
Author
dc.contributor.author
Pincetti, Christian
Author
dc.contributor.author
Pérez, Luis
Author
dc.contributor.author
Deck, Carlos
Author
dc.contributor.author
Alfaro, Mario
Author
dc.contributor.author
Vergara, María Jesús
Author
dc.contributor.author
Maluenda Razeto, Gabriel
Admission date
dc.date.accessioned
2018-07-26T21:01:45Z
Available date
dc.date.available
2018-07-26T21:01:45Z
Publication date
dc.date.issued
2018
Cita de ítem
dc.identifier.citation
Catherterization and Cardiovascular Interventions Volumen: 91 Número: 2 Páginas: 356-361
es_ES
Identifier
dc.identifier.other
10.1002/ccd.27246
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/150363
Abstract
dc.description.abstract
ObjectiveThis registry aimed to describe the safety and feasibility of a single trans-septal (TS) access technique for left intracardiac echocardiography (ICE) guidance of left-atrial appendage (LAA) closure procedure.
BackgroundLAA closure is currently accepted as an alternative to oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation (NVAF) who are at high-risk for bleeding. Currently, LAA closure procedure is typically performed under trans-esophageal echocardiogram (TEE) guidance. Although, ICE has the advantage of not requiring profound sedation/anesthesia, ICE-LAA imaging quality is often limited from the right atrium requiring double TS access.
MethodsTwenty-two patients with NVAF underwent LAA closure using the Amplatzer Amulet device (St Jude Medical) under ICE guidance from the left atrium. The ICE AcuNav catheter (Biosense Webster) and the Amulet delivery sheath were advanced into the LA through single TS puncture technique.
ResultsThe population was predominately male (59.1%) with a mean age of 749.3 years, at high-risk for stroke (mean CHADS2 score of 3.8 +/- 1.1) and bleeding (mean HAS BLED score of 3.5 +/- 1.3). The Amplatzer Amulet(TM) device was successfully implanted in all patients. No procedural related complications including device embolization were noted. No major cardiovascular events occurred and all patients were discharged alive. At 30-day follow-up all patients remained alive, free of ischemic stroke and with no residual leak or device thrombus on TEE.
ConclusionsThis initial experience suggests that LAA occlusion with the Amplatzer Amulet device using ICE guidance from the left atrium via a single trans-septal technique is feasible and safe.